BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pan H, Pan J, Li P, Gao J. Characterization of PANoptosis patterns predicts survival and immunotherapy response in gastric cancer. Clinical Immunology 2022. [DOI: 10.1016/j.clim.2022.109019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Abulaiti A, Maimaiti A, Yiming N, Fu Q, Li S, Li Y, Wang Y, Zhou Q. Molecular subtypes based on PANoptosis-related genes and tumor microenvironment infiltration characteristics in Lower-grade glioma.. [DOI: 10.21203/rs.3.rs-2541405/v1] [Reference Citation Analysis]
2 Mall R, Bynigeri RR, Karki R, Malireddi RKS, Sharma BR, Kanneganti TD. Pancancer transcriptomic profiling identifies key PANoptosis markers as therapeutic targets for oncology. NAR Cancer 2022;4:zcac033. [PMID: 36329783 DOI: 10.1093/narcan/zcac033] [Reference Citation Analysis]
3 Qiang S, Fu F, Wang J, Dong C. Definition of immune molecular subtypes with distinct immune microenvironment, recurrence, and PANoptosis features to aid clinical therapeutic decision-making. Front Genet 2022;13:1007108. [DOI: 10.3389/fgene.2022.1007108] [Reference Citation Analysis]
4 Wu Z, Zhang F, Wang Y, Lu Z, Lin C. Identification and Validation of the lncRNA MYOSLID as a Regulating Factor of Necroptosis and Immune Cell Infiltration in Colorectal Cancer following Necroptosis-Related LncRNA Model Establishment. Cancers 2022;14:4364. [DOI: 10.3390/cancers14184364] [Reference Citation Analysis]